BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33842349)

  • 1. Prognostic Value of an Immunohistochemical Signature in Patients With Bladder Cancer Undergoing Radical Cystectomy.
    Wu J; Wen JM; Wang YC; Luo WJ; Wang QF; Lv H; Dai B; Ye DW; Su HC; Zhu YP
    Front Oncol; 2021; 11():641385. PubMed ID: 33842349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of an immunohistochemical signature in patients with esophageal squamous cell carcinoma undergoing radical esophagectomy.
    Meng J; Zhang J; Xiu Y; Jin Y; Xiang J; Nie Y; Fu S; Zhao K
    Mol Oncol; 2018 Feb; 12(2):196-207. PubMed ID: 29160958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of an Immunohistochemical Signature in Patients With Head and Neck Mucosal Melanoma.
    Xu QQ; Li QJ; Huang CL; Cai MY; Zhang MF; Yin SH; Lu LX; Chen L
    Front Immunol; 2021; 12():708293. PubMed ID: 34394109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical Signature Add Prognostic Value in Patients With Early and Intermediate Hepatocellular Carcinoma Underwent Curative Liver Resection.
    Bai Y; Lian Y; Chen X; Wu J; Lai J; Qiu F; Zhou S; Zhu Z; Tian Y; Wang Y; Yang Y; Yan M
    Front Oncol; 2020; 10():616263. PubMed ID: 33585243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GeneExpressScore Signature: a robust prognostic and predictive classifier in gastric cancer.
    Zhu X; Tian X; Sun T; Yu C; Cao Y; Yan T; Shen C; Lin Y; Fang JY; Hong J; Chen H
    Mol Oncol; 2018 Nov; 12(11):1871-1883. PubMed ID: 29957874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Prognostic Signature Model with Tumor Microenvironment for predicting Disease-free Survival after Radical Prostatectomy.
    Zhao H; Zhang X; Shi Z; Guo B; Zhang W; He K; Hu X; Shi S
    J Cancer; 2021; 12(8):2371-2384. PubMed ID: 33758613
    [No Abstract]   [Full Text] [Related]  

  • 8. Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer.
    Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
    Lipids Health Dis; 2021 Oct; 20(1):146. PubMed ID: 34706720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of an immunohistochemical signature in patients with pulmonary squamous cell carcinoma undergoing complete surgical resection.
    Lin C; Xi Y; Yu H; Chen X; Shen W
    J Thorac Dis; 2022 Feb; 14(2):536-545. PubMed ID: 35280487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.
    Yu Y; Tan Y; Xie C; Hu Q; Ouyang J; Chen Y; Gu Y; Li A; Lu N; He Z; Yang Y; Chen K; Ma J; Li C; Ma M; Li X; Zhang R; Zhong H; Ou Q; Zhang Y; He Y; Li G; Wu Z; Su F; Song E; Yao H
    JAMA Netw Open; 2020 Dec; 3(12):e2028086. PubMed ID: 33289845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Nomogram based on cell growth-related Biomarkers for Oral Squamous Cell Carcinoma.
    Shuai Y; Duan Y; Zhou M; Yue K; Liu D; Fang Y; Wang Y; Wu Y; Zhang Z; Wang X
    J Cancer; 2021; 12(17):5153-5163. PubMed ID: 34335932
    [No Abstract]   [Full Text] [Related]  

  • 12. Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection.
    Liu WR; Tian MX; Tang Z; Fang Y; Zhou YF; Song SS; Jiang XF; Wang H; Tao CY; Zhou PY; Qu WF; Ding ZB; Peng YF; Zhou J; Fan J; Shi YH
    Br J Cancer; 2020 Jul; 123(1):92-100. PubMed ID: 32376890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
    Chen S; Zhao E
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
    Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
    Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Preoperative Albumin-to-Fibrinogen Ratio in Patients with Bladder Cancer.
    Li S; Zhang D; Zeng S; Wu T; Wang Y; Zhang H; Wang B; Hu X
    J Cancer; 2021; 12(19):5864-5873. PubMed ID: 34475999
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification and validation of a twelve immune infiltration-related lncRNA prognostic signature for bladder cancer.
    Liu CQ; Xia QD; Sun JX; Xu JZ; Lu JL; Liu Z; Hu J; Wang SG
    Aging (Albany NY); 2022 Feb; 14(3):1492-1507. PubMed ID: 35165206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI-Based Radiomic Signature as a Prognostic Biomarker for HER2-Positive Invasive Breast Cancer Treated with NAC.
    Li Q; Xiao Q; Li J; Duan S; Wang H; Gu Y
    Cancer Manag Res; 2020; 12():10603-10613. PubMed ID: 33149669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a Nomogram Based on a Hypoxia-Related lncRNA Signature to Improve the Prediction of Gastric Cancer Prognosis.
    Chen Q; Hu L; Chen K
    Front Genet; 2020; 11():570325. PubMed ID: 33193668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study.
    Cui Y; Zhang J; Li Z; Wei K; Lei Y; Ren J; Wu L; Shi Z; Meng X; Yang X; Gao X
    EClinicalMedicine; 2022 Apr; 46():101348. PubMed ID: 35340629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.
    Huang Y; Liu Z; He L; Chen X; Pan D; Ma Z; Liang C; Tian J; Liang C
    Radiology; 2016 Dec; 281(3):947-957. PubMed ID: 27347764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.